Strong, but Age-Dependent, Protection Elicited by a Deoxyribonucleic Acid/Modified Vaccinia Ankara Simian Immunodeficiency Virus Vaccine

Background. In this study, we analyzed the protective efficacy of a simian immunodeficiency virus (SIV) macaque 239 (SIVmac239) analogue of the clinically tested GOVX-B11 deoxyribonucleic acid (DNA)/modified vaccinia Ankara (MVA) human immunodeficiency virus vaccine. Methods. The tested vaccine used...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Chamcha, Venkateswarlu, Kannanganat, Sunil, Gangadhara, Sailaja, Nabi, Rafiq, Kozlowski, Pamela A., Montefiori, David C., LaBranche, Celia C., Wrammert, Jens, Keele, Brandon F., Balachandran, Harikrishnan, Sahu, Sujata, Lifton, Michelle, Santra, Sampa, Basu, Rahul, Moss, Bernard, Robinson, Harriet L., Amara, Rama Rao
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4800464/
https://ncbi.nlm.nih.gov/pubmed/27006959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw034
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares